perfusion reserve, ventricular function, coronary angiographic results, coronary calcification, and coronary artery inflammation offers an opportunity to bring together a constellation of important measurements to characterize coronary heart disease. These images can be recorded in an outpatient environment, pro...
PP-137 \{ATRIAL\} \{FIBRILLATION\} \{FOLLOWING\} \{ELECTIVE\} \{CORONARY\} \{BYPASS\} \{SURGERY\} \{WITHOUT\} \{CARDIOPULMONARY\} \{BYPASS\} \{IN\} \{MALE\} \{PATIENTS\} \{WITH\} \{SEVERE\} \{LV\} DYSFUNCTION: \{WHAT\} \{IS\} \{EXACT\} \{PREDICTING\} \{ROLE\}...
BC Staff - 《British Journal of Cardiology》 被引量: 0发表: 2010年 [Late cerebrovascular complications of cardiac transplantation] The occurrence of stroke after the post-operative period of cardiac transplantation is a rare event, and the role of the cardiac transplant in these patien... B, ...
We hypothesized that reductions in left atrial volume (LAV) with a cardiac resynchronization therapy–defibrillator (CRT-D) would translate into a subseque... A Brenyo,MS Link,A Barsheshet,... - 《Journal of the American College of Cardiology》 被引量: 282发表: 2011年 A simplified bivent...
Programming the pulse generator to the...doi:10.1007/s12471-018-1130-4Schroemges J.Bracke F. A. L. E.van Gelder B. M.Netherlands heart journal: monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation...
Heart Failure (HF) is one of the leading problems in cardiology practice today. Acute decompensated heart failure (ADHF) is a significant caus
Stem cell therapy has been developing for the last 40 years, and it has shown results in the treatment of different diseases, from neurological to heart and autoimmune pathologies. At the same time, in the news or on the internet, cell therapy is often promoted with alerts that it has adve...
Heart failure after myocardial infarction is the leading cause of mortality and morbidity worldwide. Existing medical and interventional therapies can only reduce the loss of cardiomyocytes during myocardial infarction but are unable to replenish the per
Heart failure after myocardial infarction is the leading cause of mortality and morbidity worldwide. Existing medical and interventional therapies can only reduce the loss of cardiomyocytes during myocardial infarction but are unable to replenish the per
The benefits of ablation plus CRT extended to all patients, regardless of LVEF. Figure 2. Results of Landmark Trials of Cardiac Resynchronization Therapy. ICM = ischemic cardiomyopathy; NICM = non-ischemic cardiomyopathy; QRSd = QRS duration; LVEDD = left ventricular end diastolic volume; 6MWD ...